Swimmers and surfers today are about 90 percent less likely to be attacked by sharks off California's coast than they were in the 1950s, even though there are hundreds of thousands more people in the water, according to a new study.
CytoDyn believes that complete virologic suppression through treatment with a single agent, rather than through the widely used HAART combination therapy, could present a significant opportunity to treat HIV infection.
Merck has announced the start of "More than a Mother" campaign as part of Merck Fertility Capacity Advancement Program, in collaboration with University of Nairobi and Kenya Women Parliamentary Association.
The FDA has revised its warning about anti-inflammatory drugs, cautioning users about their risks. CBS News chief medical correspondent Dr. Jon LaPook explains.
Researchers created a model of an HIV capsid protein, then used X-ray crystallography to unravel the protein's secrets.
The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.
"Because International" is a nonprofit that has developed a new children's shoe that expands up to five sizes.
Their prey has been human: In a 28-day span, eight people have been bitten by sharks in North Carolina, a new high for the 80 years in which records have been kept.
Leading HIV/AIDS experts issued three policy briefs for ensuring that the Ryan White HIV/AIDS Program is updated to be maximally effective in a changing health care environment.
A CDC report shows a 63 percent increase in heroin use over the last decade.